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Case Report
A Case of Crystalline Keratopathy in Monoclonal 
Gammopathy of Undetermined Significance (MGUS)
Hyun Koo, Doo‐Hwan Oh, Yeoun Sook Chun, Jae Chan Kim
Department of Ophthalmology, Chung‐Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
A 62-year-old female visited our clinic with progressively decreased vision in both eyes beginning 12 years prior. 
Idiopathic corneal opacity in all layers of the cornea was found in both eyes. One year later, we performed penetrat-
ing keratoplasty on the undiagnosed right eye. During post-surgical follow-up, corneal edema and stromal opacity 
recurred, and penetrating keratoplasty was performed two more times. The patient’s total serum protein level, which 
had previously been normal, was elevated prior to the final surgery. She was diagnosed with monoclonal gammop-
athy of undetermined significance. We made a final diagnosis of monoclonal gammopathy-associated crystalline 
keratopathy after corneal biopsy. Monoclonal gammopathy-associated crystalline keratopathy is difficult to diag-
nose and may lead to severe visual loss. A systemic work-up, including serologic tests like serum protein or choles-
terol levels, is needed in patients with unexplainable corneal opacity.
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Monoclonal gammopathy of undetermined significance 
(MGUS) is a benign asymptomatic plasma cell neoplasm 
containing monoclonal protein (M protein). MGUS is de-
fined as a serum M protein level less than 3.0 g/dL and bone 
marrow plasma cell level less than 10% [1]. Diagnosis of this 
disease is made by detection of M protein in blood or urine 
samples. Since MGUS is asymptomatic, it is usually detected 
incidentally during routine laboratory evaluation [2].
Corneal involvement in monoclonal gammopathy is a very 
rare complication and is difficult to diagnose. According to 
Garibaldi, corneal disease was detected in one of 100 mono-
clonal gammopathy patients [3]. Corneal opacities occurring 
in various layers caused by abnormal protein deposition are 
the most common features, and these deposits can appear in 
many shapes when examined under electron microscopy. In 
most cases, there are no symptoms or minimal foreign body 
sensations and glare. Few cases of MGUS patients have been 
reported to show corneal crystalline deposits. We report here 
on a severe case of crystalline keratopathy caused by mono-
clonal gammopathy in a patient who underwent three pene-
trating keratoplasty procedures.
Case Report
A 62-year-old female presented to our clinic in July 1996 
with progressively decreased visual acuity and pain in both 
eyes that had begun 12 years prior. Her visual acuity was 
counting fingers at a distance of 50 cm from the right eye, 
while that of the left eye was 0.06. Corneal stromal edema 
and Descemet’s folds were found in both eyes (Fig. 1A). 
Corneal opacity was involved in all layers of the cornea, and 
epithelial bullas were found in the center of the right cornea. 
Lens, vitreous, and fundus were normal. The patient had nei-
ther a personal medical history nor familial history of eye 
disease. We performed penetrating keratoplasty in the right 
eye without a precise diagnosis. Visual acuity was main-
tained at 0.2 during the first few months after surgery.
Visual acuity proceeded to decrease, and ocular pain re-
curred four years after the first surgery. Right eye visual acui-
ty was hand motion, and slit-lamp biomicroscopy showed re-
currence of epithelial edema and stromal opacity (Fig. 1B). 
In July 2005, the patient underwent a second penetrating ker-
atoplasty in the right eye due to recurrent corneal opacity and 
neovascularization in the cornea. Despite mild corneal opac-
ity and corneal edema, visual acuity was maintained at 0.08 
during the first two years after the second surgery.
A third penetrating keratoplasty was performed on the right H Koo, et al. Crystalline Keratopathy in Monoclonal Gammopathy
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Fig. 1. Slit-lamp photographs of recurring corneal opacity in a crystalline keratopathy patient with monoclonal gammopathy of un-
determined significance despite keratoplasty surgeries. (A) Before the penetrating keratoplasty, corneal stromal edema, opacity and 
Descemet’s folds presented in both eyes. (B) Four years after the first surgery, corneal opacity recurred in the right eye. (C) 
Photograph showing corneal opacity two years after the second keratoplasty.
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Fig. 2. Corneal biopsy photographs from a crystalline keratopathy patient. (A) Hematoxylin and eosin staining showing loss of polar-
ity, with clusters in the epithelium (×100). (B) Hematoxylin and eosin staining showing a decreased number of endothelial cells with 
some vacuoles in Descemet’s membrane (×40). (C) TUNEL staining showing increased keratocyte apoptosis with condensed nuclei 
(×100). (D) Masson trichrome staining showing deposits in the corneal stroma (×40).
eye in July 2008, due to worsened corneal opacity and visual 
acuity decrease to 0.02 (Fig. 1C). Total serum protein level, 
which had remained at a normal level until 2008, was elevated 
to 10.4 g/dL after preoperative evaluation. Electrophoresis re-
vealed elevated M protein in the serum (2.72 g/dL) and urine 
(29.3 mg/dL). Immunofixation electrophoresis showed ele-
vated kappa light chains. Bone marrow smears depicted a 
plasma cell concentration of 2.4%, and there were no mor-
phological abnormalities. The patient was diagnosed with 
type IgG-kappa MGUS and was transferred to the hema-
to-oncology department for further examination.
In the hemato-oncology department, corneal biopsy of the 
right eye was performed. The corneal epithelial layer showed 
loss of polarity and clusters of epithelial cells (Fig. 2A). A de-Korean J Ophthalmol Vol.25, No.3, 2011
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Fig. 3. Electron microscopic photographs of crystalline keratopathy. (A) Microtubular crystal deposits were found around a kera-
tocyte whose chromatin was condensed (×28,000). (B) Crystal deposits phagocytosed by a macrophage (white arrow) (×28,000). 
(C) Vacuoles in the endothelium (black arrow) and loss of microvilli (arrow head) (×10,000). (D) Abnormal banded collagen fi-
brils were seen with a background of amorphous material in the posterior portion of Descemet’s membrane (×28,000).
creased number of endothelial cells accompanied by the 
presence of vacuoles in the Descemet’s membrane were de-
tected (Fig. 2B). TUNEL staining typically shows condensed 
or fragmented nuclei in apoptotic cells. In this case, TUNEL 
staining of the cornea showed increased keratocyte apoptosis 
with condensed nuclei (Fig. 2C). Numerous eosinophilic de-
posits were stained bright red with Masson trichrome stain 
and were thought to be IgG-kappa light chains, the levels of 
which were elevated in this patient (Fig. 2D).
Electron microscopy depicted numerous microtubular-shaped 
deposits located extracellulary near corneal epithelial cells, 
stromal cells, and Descemet’s membrane. These microtubular 
deposits surrounded keratocytes, which contained condensed 
chromatin (Fig. 3A). A portion of these deposits appeared to 
be phagocytosed by macrophages (Fig. 3B). However, in 
monoclonal gammopathy, phagocytosis is not sufficient to 
remove all abnormal crystal deposits. In addition, vacuoles 
and loss of microvilli in endothelial cells and abnormal band-
ed collagen fibrils in the posterior portion of Descemet’s 
membrane were observed (Fig. 3C and 3D). This demon-
strates that deposition of abnormal protein crystals can affect 
not only keratocytes but also endothelial cells and the colla-
gen matrix in the stroma.
Discussion
Monoclonal gammopathy-associated crystalline keratop-
athy was first reported in a multiple myeloma patient by 
Meesman in 1934 [4]. Only 1% of monoclonal gammopathy 
patients show crystal deposits, including a case of a multiple 
myeloma in a patient from Korea in 2009 [5]. Primary symp-
toms include corneal crystal deposits and corneal opacity. 
Corneal opacity may be the first clinical symptom of mono-
clonal gammopathy and affects the corneal epithelium and 
stroma. Endothelial dysfunction plays a major role in corneal 
opacity, but the association between corneal endothelial dys-H Koo, et al. Crystalline Keratopathy in Monoclonal Gammopathy
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function and crystal deposition is not clear. Although there 
have been some reports of decreased corneal opacity with 
systemic treatment, some patients still require penetrating 
keratoplasty.
Extracellular deposition of M protein creates the crystals 
found in the cornea. These crystal depositions can involve all 
layers of the cornea and vary in shape (e.g., rectangular or 
hexagonal), location (corneal epithelium, stroma, endothelium, 
conjunctiva and lens), and resulting symptoms [4]. The typi-
cal shape of crystals observed under electron microscopy is 
the 10 nm 13 nm parallel band shape [6-8]. The etiology of 
this crystal deposition is not clear. However, from the patho-
logical findings of this case, we can assume that phagocytic 
activity in the cornea is insufficient to manage the mono-
clonal proteins so that these over-produced proteins are de-
posited in extracellular areas and lead to keratocyte apoptosis.
In this case, diagnosis was complicated due to differences 
in clinical presentation after each penetrating keratoplasty. 
The diagnosis of crystalline keratopathy was made after 
MGUS was confirmed and crystalline deposits had been 
detected. Because corneal crystal deposition is a rare finding 
in monoclonal gammopathy patients, various diagnoses such 
as lattice dystrophy, Schnyders crystalline dystrophy, granular 
dystrophy, and cystein deposition can be suspected, partic-
ularly when crystal deposition presents as the first symptom 
[9-12]. 
It is clinically difficult to distinguish crystalline keratopathy 
from the other diseases above. Histological examinations of 
corneal biopsy and systemic evaluations to confirm the crystal- 
producing condition are required to make a firm diagnosis. 
This is a good example of an ophthalmologic case that re-
quires systemic evaluation in surveillance of systemic disease 
progression or for measurement of disease severity.
Corneal allograft rejection and recurrence of corneal crystal 
deposition can be distinguished easily in the clinic. The main 
difference between rejection and recurrence is the rate of 
progression. Corneal graft rejection most commonly occurs 
during the first year after surgery and presents with the severe 
and acute symptoms of blurring of vision, eye redness and 
pain. In contrast, corneal crystal depositions occur relatively 
slowly and cause less severe symptoms, and most corneal 
crystal depositions are asymptomatic. However, some cases 
can cause progressive pain and blurred vision. As in this 
case, fast progressing and painful corneal crystal depositions 
can only be distinguished from corneal allograft rejection via 
corneal biopsy.
The current standard of care for MGUS is observation 
without treatment. Patients with MGUS need to be rechecked 
after 3-4 months for progression of MGUS to multiple mye-
loma, amyloidosis, or non-Hodgkin’s lymphoma. According 
to Kyle [13], the progression rate of MGUS to malignant dis-
ease is 1% per year. 
Although MGUS is a benign plasma cell disorder, crystal-
line keratopathy can occur and may progress to severe vision 
loss. Because MGUS is an asymptomatic disease, and only 
decreased vision with corneal opacities can be found in the 
early presentations, a systemic work-up that includes sero-
logic tests such as serum protein or cholesterol level is need-
ed for patients with unexplainable corneal opacity. On the 
other hand, the eyes of patients diagnosed with monoclonal 
gammopathy should be carefully examined. Adequate treat-
ments, including surgery, are often required.
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